NCT00474695View on ClinicalTrials.gov

Study Evaluating Genotypes Using Lucentis

TerminatedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions
Age-Related Maculopathy
Interventions
DRUG

Lucentis

0.05 mg intravitreal injection

Trial Locations (3)

80210

Porter Adventist Hospital, Denver

84132

University of Utah, Moran Eye Center, Salt Lake City

93103

California Retina Consultants, Santa Barbara

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Utah

OTHER